Literature DB >> 19498437

Diagnosis of pheochromocytoma in the setting of Parkinson disease.

Shyamal H Mehta1, Rajan Prakash, L Michael Prisant, Carlos M Isales, John C Morgan, Hadyn Williams, Kapil D Sethi.   

Abstract

BACKGROUND: A 59-year-old man with a 7-year history of Parkinson disease (PD) presented with episodes of sudden, severe headaches with neck pain, tachycardia, sweating and pallor. During these episodes, the patient showed marked elevations in blood pressure, regardless of posture. This was unusual, given that he had no prior history of hypertension. The array of symptoms raised suspicions of pheochromocytoma, but diagnosis was challenging, as the standard diagnostic biochemical tests were confounded by dopaminergic medications. Further work-up revealed left adrenal medullary hyperplasia. Several reports exist of pseudopheochromocytoma in patients on dopaminergic therapy, but this is the first documented case of pheochromocytoma syndrome due to adrenal medullary hyperplasia in a patient with PD. This case highlights the challenges of performing a diagnostic work-up in a PD patient with symptoms suggestive of pheochromocytoma, and illustrates the utility of (123)I-metaiodobenzylguanidine ((123)I-MIBG) single-photon emission CT in making a diagnosis.Investigations. Physical examination, laboratory tests, abdominal MRI scan, abdominal (123)I-MIBG scan, abdominal (18)F-fluorodeoxyglucose PET scan. DIAGNOSIS: Pheochromocytoma syndrome due to adrenal medullary hyperplasia.Management. Surgical excision of the left adrenal gland.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19498437     DOI: 10.1038/nrneurol.2009.55

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  19 in total

1.  Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.

Authors:  D F Davidson; K Grosset; D Grosset
Journal:  Ann Clin Biochem       Date:  2007-07       Impact factor: 2.057

2.  Laparoscopic compared with open adrenalectomy for resection of pheochromocytoma: a review of 47 cases.

Authors:  Robert Humphrey; Daryl Gray; Stephen Pautler; Ward Davies
Journal:  Can J Surg       Date:  2008-08       Impact factor: 2.089

3.  Pseudopheochromocytoma in a patient with Parkinson's disease.

Authors:  J Duarte; A P Sempere; C Cabezas; T Calvo; L E Claveria
Journal:  Ann Pharmacother       Date:  1996-05       Impact factor: 3.154

4.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

5.  The role of chromogranin A in the management of patients with phaeochromocytoma.

Authors:  Erika Grossrubatscher; Paolo Dalino; Federico Vignati; Marcello Gambacorta; Raffaele Pugliese; Marco Boniardi; Ornella Rossetti; Alessandro Marocchi; Michaela Bertuzzi; Paola Loli
Journal:  Clin Endocrinol (Oxf)       Date:  2006-09       Impact factor: 3.478

6.  False positive diagnosis of phaeochromocytoma in a patient with Parkinson's disease receiving levodopa.

Authors:  N Quinn; M Carruthers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

7.  Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.

Authors:  H Lefebvre; C Noblet; N Moore; L M Wolf
Journal:  Clin Endocrinol (Oxf)       Date:  1995-01       Impact factor: 3.478

Review 8.  The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.

Authors:  S Braune
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

9.  Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.

Authors:  Frédéric Courbon; Christine Brefel-Courbon; Claire Thalamas; Marie-Jeanne Alibelli; Isabelle Berry; Jean-Louis Montastruc; Olivier Rascol; Jean-Michel Senard
Journal:  Mov Disord       Date:  2003-08       Impact factor: 10.338

Review 10.  A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG).

Authors:  K K Solanki; J Bomanji; J Moyes; S J Mather; P J Trainer; K E Britton
Journal:  Nucl Med Commun       Date:  1992-07       Impact factor: 1.690

View more
  2 in total

1.  A Rare Coexistence of Pheochromocytoma and Parkinson's Disease With Diagnostic Challenges.

Authors:  Erika Matsumura-Matsuda; Motohiro Sekiya; Miyoko Omoto-Inuzuka; Kana Santo; Akito Shikama; Motoko Kuba; Yoko Sugano; Hitoshi Iwasaki; Shigeru Yatoh; Taiki Sato; Hisato Hara; Kazuhiro Takekoshi; Hiroaki Suzuki; Hitoshi Shimano
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

2.  Adrenal Pheochromocytoma Incidentally Discovered in a Patient With Parkinsonism.

Authors:  Luigi Petramala; Antonio Concistrè; Cristiano Marinelli; Laura Zinnamosca; Gino Iannucci; Piernatale Lucia; Giuseppe De Vincentis; Claudio Letizia
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.